Scinovex
review Open AccessTop 1% cited

GPCR Signaling Regulation: The Role of GRKs and Arrestins

Frontiers in Pharmacology · 2019 · Vol. 10
Vsevolod V. GurevichEugenia V. Gurevich

Abstract

Every animal species expresses hundreds of different G protein-coupled receptors (GPCRs) that respond to a wide variety of external stimuli. GPCRs-driven signaling pathways are involved in pretty much every physiological function and in many pathologies. Therefore, GPCRs are targeted by about a third of clinically used drugs. The signaling of most GPCRs via G proteins is terminated by the phosphorylation of active receptor by specific kinases (GPCR kinases, or GRKs) and subsequent binding of arrestin proteins, that selectively recognize active phosphorylated receptors. In addition, GRKs and arrestins play a role in multiple signaling pathways in the cell, both GPCR-initiated and receptor-independent. Here we focus on the mechanisms of GRK- and arrestin-mediated regulation of GPCR signaling, which includes homologous desensitization and redirection of signaling to additional pathways by bound arrestins.

Receptor Mechanisms and SignalingNeuropeptides and Animal PhysiologyProtein Kinase Regulation and GTPase SignalingG protein-coupled receptorG protein-coupled receptor kinaseArrestinCell biologySignal transductionRhodopsin-like receptorsBiologyPhosphorylationReceptorBeta adrenergic receptor kinase

Funding

  • National Institutes of Health
Citations
542
FWCI
23.13
field-weighted impact
References
153
Percentile
100%
vs. same field & year
Citations per year
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.

GPCR Signaling Regulation: The Role of GRKs and Arrestins · Scinovex